U.S. Physical Therapy (NYSE:USPH) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

U.S. Physical Therapy (NYSE:USPH) announced its quarterly earnings data on Wednesday. The company reported $0.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.67 by ($0.01), Zacks reports. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The business had revenue of $197.13 million during the quarter, compared to analysts’ expectations of $193.98 million. During the same period in the prior year, the company posted $0.69 earnings per share. The firm’s revenue was up 17.3% on a year-over-year basis.

U.S. Physical Therapy Trading Down 11.9%

U.S. Physical Therapy stock opened at $77.56 on Friday. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.19. The company’s fifty day moving average price is $85.61 and its two-hundred day moving average price is $79.93. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 4.41 and a beta of 1.47.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 12th. Shareholders of record on Monday, November 17th will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio is presently 78.60%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $83.53, for a total transaction of $167,060.00. Following the completion of the sale, the chief executive officer owned 114,088 shares of the company’s stock, valued at $9,529,770.64. This represents a 1.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Carey P. Hendrickson sold 698 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the completion of the transaction, the chief financial officer directly owned 27,808 shares in the company, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 6,853 shares of company stock worth $581,406 in the last 90 days. Insiders own 2.00% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

Several hedge funds have recently added to or reduced their stakes in USPH. State of Wyoming increased its stake in U.S. Physical Therapy by 85.3% during the second quarter. State of Wyoming now owns 1,575 shares of the company’s stock valued at $123,000 after acquiring an additional 725 shares during the period. Tower Research Capital LLC TRC grew its holdings in shares of U.S. Physical Therapy by 377.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,746 shares of the company’s stock worth $137,000 after purchasing an additional 1,380 shares in the last quarter. Brevan Howard Capital Management LP acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $289,000. Hsbc Holdings PLC acquired a new position in shares of U.S. Physical Therapy in the second quarter valued at $410,000. Finally, Snowden Capital Advisors LLC lifted its holdings in shares of U.S. Physical Therapy by 3.6% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock worth $438,000 after acquiring an additional 195 shares during the period.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on USPH. Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Barrington Research restated an “outperform” rating and set a $103.00 price target on shares of U.S. Physical Therapy in a report on Friday, October 24th. Finally, JPMorgan Chase & Co. initiated coverage on shares of U.S. Physical Therapy in a research note on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.